TOG Review (RCOG Journal)

MRCOG Part 2

Postpartum Problems (Maternal)

Placental histopathological abnormalities and poor perinatal outcomes

Key Statistics

  • 40% — Stillbirths with fetal growth restriction
  • >50% — Stillbirths with placental pathology as cause (2014 SR)
  • 0.28/1000 — MPVFD incidence (irish tertiary cohort)

Don't-miss facts

  1. Placenta storage: 4°C, sealed container, never frozen – freezing destroys microscopic features

  2. Essential indications: stillbirth, late miscarriage, severe fetal distress → NNU, prematurity <30+0/40, FGR <3rd centile, fetal hydrops, maternal pyrexia >38°C

  3. MPVFD = fibrin/fibrinoid surrounding ≥30% of distal villi; also termed maternal floor infarction (misnomer – no true infarct); recurrence risk 40–60%

  4. FTV definition: ≥15 avascular villi or stromal-vascular karyorrhexis in ≥2 foci/slide, without VUE; lesions focal (diffuse pattern instead suggests post-stillbirth change)

  5. VUE: T-cell infiltration of villi, 5–15% of near-term placentas, usually >32/40; possible graft-versus-host mechanism

  6. Villous dysmaturity strongly linked to maternal diabetes (80% of diabetic placentas, Daskalakis 2008) – chronic fetal hypoxaemia

  7. Chorioamnionitis grade 2 (severe) = ≥3 chorionic micro-abscesses (Redline 2003)

  8. Recurrence risk for counselling: MVM 10–25%, MPVFD 40–60%, VUE 25–50%

Lesion groups (redline 2015)

Vascular: MVM Immune: VUE, chorioamnionitis

Other: MPVFD, FTV, villous dysmaturity, cord/shape variants, accreta, meconium change

Abbreviation Key

  • CT — cytotrophoblast
  • FTV — fetal thrombotic vasculopathy
  • ST — syncytiotrophoblast
  • VUE — villitis of unknown aetiology
  • MVM — maternal vascular malperfusion
  • RCPath — Royal College of Pathologists
  • MPVFD — massive perivillous fibrin deposition
  • LMWH — low molecular weight heparin
  • MFI — maternal floor infarction
  • hCG — human chorionic gonadotrophin

Source: Thirumalaikumar L, Ramalingam K, Marton T. Placental histopathological abnormalities and poor perinatal outcomes. The Obstetrician & Gynaecologist 2019;21:135–142. doi:10.1111/tog.12555

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free